The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Thermo Fisher Scientific
Improving clinical trial label translation through centralized reuse and control
Centralized translation and label approval enabled scalable, compliant clinical label development across global trials, reducing duplication, cost, and timelines.
As clinical trials expand across regions and languages, label translation can become a source of duplication, cost, and inconsistency. Without a centralized approach, previously approved content is often recreated across studies, increasing effort and introducing variability.
This case study explores how a structured translation framework enabled reuse of validated content across global trials, supporting more consistent label development while reducing timelines and cost.
Key outcomes of using centralized translation framework:
This approach delivered measurable improvements across efficiency, consistency, and cost control, including:
- Faster clinical trial startup timelines
- Reduced duplication and operational costs
- Improved consistency across multilingual labels
- Scalable processes for global trial expansion
